Correction to: Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials
Crossref DOI link: https://doi.org/10.1186/s10194-021-01253-3
Published Online: 2021-05-25
Published Print: 2021-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Smith, Timothy R.
Spierings, Egilius L. H.
Cady, Roger
Hirman, Joe
Schaeffler, Barbara
Shen, Vivienne
Sperling, Bjørn
Brevig, Thomas
Josiassen, Mette Krog
Brunner, Elizabeth
Honeywell, Loan
Mehta, Lahar
Text and Data Mining valid from 2021-05-25
Version of Record valid from 2021-05-25
Article History
First Online: 25 May 2021